博拓生物：8月27日召开董事会会议

Group 1 - The core point of the article is that Botao Bio (SH 688767) announced the convening of its fourth second board meeting on August 27, 2025, to review the semi-annual report and its summary for 2025 [1] - For the year 2024, Botao Bio's revenue composition is reported as 92.91% from in vitro diagnostic test strips and 7.09% from other businesses [1] - As of the report, Botao Bio has a market capitalization of 5.9 billion yuan [1]